REINSURANCE GROUP OF AMERICA INC
For the period ended Jun 30, 2025. Filed Aug 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table summarizes RGA’s repurchase activity of its common stock during the quarter ended June 30, 2025:
| Total Number of SharesPurchased (1) | Average Price Paid per Share | Total Number of SharesPurchased as Part ofPublicly Announced Plansor Programs (1) | Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plan or Program | |
|---|---|---|---|---|
| April 1, 2025 – April 30, 2025 | 237 | $185.21 | — | $500,000,000 |
| May 1, 2025 – May 31, 2025 | 1,550 | $203.61 | — | $500,000,000 |
| June 1, 2025 – June 30, 2025 | 519 | $199.15 | — | $500,000,000 |
(1)The Company did not repurchase any shares of common stock under its share repurchase program in April, May and June 2025. The Company net settled– issuing 766, 5,530 and 1,776 shares from treasury and repurchasing from recipients 237, 1,550 and 519 shares in April, May and June 2025, respectively, in settlement of income tax withholding requirements incurred by the recipients of equity incentive awards.
On January 23, 2024, the Company’s board of directors authorized a share repurchase program for up to $500 million of its outstanding common stock. The authorization was effective immediately and does not have an expiration date. During the six months ended June 30, 2025, the Company did not repurchase any shares of common stock under this program, and the entire amount remains available.
The pace of repurchase activity depends on various factors such as the level of available cash, an evaluation of the costs and benefits associated with alternative uses of excess capital, such as acquisitions and in force reinsurance transactions, and the Company’s stock price.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.